Actinogen Medical Ltd
ASX:ACW

Watchlist Manager
Actinogen Medical Ltd Logo
Actinogen Medical Ltd
ASX:ACW
Watchlist
Price: 0.056 AUD -5.08% Market Closed
Market Cap: 178.2m AUD

Wall Street
Price Targets

ACW Price Targets Summary
Actinogen Medical Ltd

Wall Street analysts forecast ACW stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACW is 0.082 AUD with a low forecast of 0.081 AUD and a high forecast of 0.084 AUD.

Lowest
Price Target
0.081 AUD
44% Upside
Average
Price Target
0.082 AUD
46% Upside
Highest
Price Target
0.084 AUD
50% Upside
Actinogen Medical Ltd Competitors:
Price Targets
CRVO
Diffusion Pharmaceuticals Inc
170% Upside
CCCC
C4 Therapeutics Inc
446% Upside
ZYME
Zymeworks Inc
35% Upside
VCEL
Vericel Corp
49% Upside
688428
InnoCare Pharma Ltd
84% Upside
BVXP
Bioventix PLC
121% Upside
TVTX
Travere Therapeutics Inc
5% Upside
NIOX
Niox Group PLC
23% Upside

Revenue
Forecast

Revenue Estimate
Actinogen Medical Ltd

For the last 13 years the compound annual growth rate for Actinogen Medical Ltd's revenue is 22%. The projected CAGR for the next 2 years is 470%.

22%
Past Growth
470%
Estimated Growth
Estimates Accuracy
-96%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Actinogen Medical Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Actinogen Medical Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-40%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACW's stock price target?
Price Target
0.082 AUD

According to Wall Street analysts, the average 1-year price target for ACW is 0.082 AUD with a low forecast of 0.081 AUD and a high forecast of 0.084 AUD.

What is Actinogen Medical Ltd's Revenue forecast?
Projected CAGR
470%

For the last 13 years the compound annual growth rate for Actinogen Medical Ltd's revenue is 22%. The projected CAGR for the next 2 years is 470%.

Back to Top